Genotek Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

Genotek General Information

Description

Operator of a DNA testing services platform intended to serve clients with access to genetic information. The company's platform includes DNA analysis, genetic tests, research of predisposition to diseases to reveal and prevent rare hereditary diseases, finding relatives, determining the origin and national composition, enabling people to be medically informed, and improving their quality of life.

Contact Information

Website
www.genotek.ru
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bolshaya Polyanka Street 44/2
  • Moscow, 105120
  • Russia
+7 8
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Biotechnology
Vertical(s)
Corporate Office
  • Bolshaya Polyanka Street 44/2
  • Moscow, 105120
  • Russia
+7 8

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genotek Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 12-Sep-2021 Completed Generating Revenue
8. Later Stage VC 23-Dec-2020 Completed Generating Revenue
7. Later Stage VC 30-Dec-2016 Completed Generating Revenue
6. Later Stage VC 09-Feb-2016 Completed Generating Revenue
5. Accelerator/Incubator 19-Jan-2015 Completed Startup
4. Accelerator/Incubator 11-Dec-2013 Completed Startup
3. Early Stage VC 01-Dec-2013 Completed Startup
2. Accelerator/Incubator 01-Feb-2013 Completed Startup
1. Accelerator/Incubator 28-Dec-2012 Completed Startup
To view Genotek’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genotek Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genotek Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
MSU Science Park Accelerator/Incubator
Nebius Group Corporation Minority
Pharmstandard Corporation Minority
Genome Ventures Venture Capital Minority
API Moscow Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Genotek FAQs

  • When was Genotek founded?

    Genotek was founded in 2010.

  • Where is Genotek headquartered?

    Genotek is headquartered in Moscow, Russia.

  • What is the size of Genotek?

    Genotek has 60 total employees.

  • What industry is Genotek in?

    Genotek’s primary industry is Laboratory Services (Healthcare).

  • Is Genotek a private or public company?

    Genotek is a Private company.

  • What is Genotek’s current revenue?

    The current revenue for Genotek is .

  • How much funding has Genotek raised over time?

    Genotek has raised $7.6M.

  • Who are Genotek’s investors?

    MSU Science Park, Nebius Group, Pharmstandard, Genome Ventures, and API Moscow are 5 of 8 investors who have invested in Genotek.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »